J1815
J1815 – Injection, insulin, per 5 units · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 53 NDCs crosswalked
📋 J1815 summary
J1815 is a HCPCS Level II J-code used to bill insulin, per 5 units. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J1815: Awiqli, Basaglar Tempo Pen, Humalog Tempo Pen
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ1815
DescriptorInjection, insulin, per 5 units
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs53
Data periodNot available in current dataset
Last updatedSource date not available
💊 About Insulin Aspart (rDNA Origin) Injection DRUG GUIDE
Insulin aspart is used to improve blood sugar (glucose) control in people with diabetes mellitus.
It is approved for both type 1 and type 2 diabetes in adults, and for diabetes mellitus in pediatric patients.Insulin Aspart Protamine and Insulin Aspart Mix 70/30 is a pre-mixed product that combines a rapid-acting and an intermediate-acting insulin aspart.
It is approved to improve blood sugar control in adult patients with diabetes mellitus.
It is not recommended for treating diabetic ketoacidosis, and because its ratio of rapid-acting to intermediate-acting insulin is fixed, it does not allow for separate mealtime versus background dose adjustments.
Clinical overview from our editorial drug guide for Insulin Aspart (rDNA Origin) Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS
Medicare payment limit / unit
—
Est. ASP / unit
—
Est. after 2% sequester
—
HCPCS dosage
—
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).
Full HCPCS code details (official CMS record)
Long descriptionInjection, insulin, per 5 units
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2003-01-01
Date added2003-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J1815 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J1815 LEAST EXPENSIVE FIRST
53 NDCs map to J1815. Bill units = how many HCPCS units one package represents.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|
| 00002-8715-01 | Humulin 70/30 Insulin human 100 [iU]/mL INJECTION, SUSPENSION | Eli | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-8715-... | 100 [iU]/mL | 20 | $4.258 | ● Active | PDAC |
| 00002-8215-01 | Humulin R Insulin human 100 [iU]/mL INJECTION, SOLUTION | Eli | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-8215-... | 100 [iU]/mL | 20 | $4.264 | ● Active | PDAC |
| 00002-8315-01 | Humulin N Insulin human 100 [iU]/mL INJECTION, SUSPENSION | Eli | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-8315-... | 100 [iU]/mL | 20 | $4.267 | ● Active | PDAC |
| 00169-1834-11 | Novolin N Human Insulin 100 [iU]/mL INJECTION, SUSPENSION | Novo | 1 VIAL in 1 CARTON (0169-1834-11) / 10 mL... | 100 [iU]/mL | 20 | $4.621 | ● Active | PDAC |
| 00169-1833-11 | Novolin R Human Insulin 100 [iU]/mL INJECTION, SOLUTION | Novo | 1 VIAL in 1 CARTON (0169-1833-11) / 10 mL... | 100 [iU]/mL | 20 | $4.625 | ● Active | PDAC |
| 00169-1837-11 | Novolin 70/30 Human Insulin 100 [iU]/mL INJECTION, SUSPENSION | Novo | 1 VIAL in 1 CARTON (0169-1837-11) / 10 mL... | 100 [iU]/mL | 20 | $4.628 | ● Active | PDAC |
| 00088-2220-33 | Lantus insulin glargine 100 [iU]/mL INJECTION, SOLUTION | sanofi-aventis | 1 VIAL, GLASS in 1 CARTON (0088-2220-33)... | 100 [iU]/mL | 20 | $6.149 | ● Active | PDAC |
| 00169-3685-12 | NovoLog Mix 70/30 insulin aspart 100 [iU]/mL INJECTION, SUSPENSION | Novo | 1 VIAL, GLASS in 1 CARTON (0169-3685-12)... | 100 [iU]/mL | 20 | $6.928 | ● Active | PDAC |
| 73070-0200-11 | Insulin Aspart Protamine and Insulin Aspart Mix 70/30 100 [iU]/mL INJECTION, SUSPENSION | Novo | 1 VIAL, GLASS in 1 CARTON (73070-200-11)... | 100 [iU]/mL | 20 | $6.955 | ● Active | PDAC |
| 00002-7728-01 | LYUMJEV Insulin lispro-aabc 100 [iU]/mL INJECTION, SOLUTION | Eli | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-7728-... | 100 [iU]/mL | 20 | $7.876 | ● Active | PDAC |
| 00002-7511-01 | Humalog Mix75/25 Insulin lispro 100 [iU]/mL INJECTION, SUSPENSION | Eli | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-7511-... | 100 [iU]/mL | 20 | $8.149 | ● Active | PDAC |
| 00169-3205-15 | Fiasp insulin aspart injection 100 [iU]/mL INJECTION, SOLUTION | Novo | 5 CARTRIDGE in 1 CARTON (0169-3205-15) /... | 100 [iU]/mL | 20 | $8.538 | ● Active | PDAC |
| 00169-3303-12 | NOVOLOG insulin aspart 100 [iU]/mL INJECTION, SOLUTION | Novo | 5 CARTRIDGE in 1 CARTON (0169-3303-12) /... | 100 [iU]/mL | 20 | $8.573 | ● Active | PDAC |
| 00169-3204-15 | Fiasp insulin aspart injection 100 [iU]/mL INJECTION, SOLUTION | Novo | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3204-... | 100 [iU]/mL | 20 | $8.912 | ● Active | PDAC |
| 73070-0203-15 | Insulin Aspart Protamine and Insulin Aspart Mix 70/30 100 [iU]/mL INJECTION, SUSPENSION | Novo | 5 SYRINGE, PLASTIC in 1 CARTON (73070-203-... | 100 [iU]/mL | 20 | $8.935 | ● Active | PDAC |
| 00169-6339-10 | NOVOLOG insulin aspart 100 [iU]/mL INJECTION, SOLUTION | Novo | 5 SYRINGE, PLASTIC in 1 CARTON (0169-6339-... | 100 [iU]/mL | 20 | $8.936 | ● Active | PDAC |
| 00169-3696-19 | NovoLog Mix 70/30 insulin aspart 100 [iU]/mL INJECTION, SUSPENSION | Novo | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-... | 100 [iU]/mL | 20 | $8.939 | ● Active | PDAC |
| 00002-7516-59 | Humalog Insulin lispro 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 CARTRIDGE in 1 CARTON (0002-7516-59) /... | 100 [iU]/mL | 20 | $9.783 | ● Active | PDAC |
| 00002-8213-05 | Humalog Tempo Pen Insulin lispro 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 SYRINGE in 1 CARTON (0002-8213-05) / 3... | 100 [iU]/mL | 20 | $10.127 | ● Active | PDAC |
| 00002-8798-59 | Humalog Mix50/50 KwikPen Insulin lispro 100 [iU]/mL INJECTION, SUSPENSION | Eli | 5 SYRINGE in 1 CARTON (0002-8798-59) / 3... | 100 [iU]/mL | 2 | $10.143 | ● Active | PDAC |
| 00002-8207-05 | LYUMJEV KwikPen Insulin lispro-aabc 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 SYRINGE in 1 CARTON (0002-8207-05) / 3... | 100 [iU]/mL | 20 | $10.157 | ● Active | PDAC |
| 00002-7714-59 | Humalog Junior KwikPen Insulin lispro 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 SYRINGE in 1 CARTON (0002-7714-59) / 3... | 100 [iU]/mL | 20 | $10.160 | ● Active | PDAC |
| 00002-8799-59 | Humalog KwikPen Insulin lispro 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 SYRINGE in 1 CARTON (0002-8799-59) / 3... | 100 [iU]/mL | 20 | $10.169 | ● Active | PDAC |
| 00002-8797-59 | Humalog Mix75/25 KwikPen Insulin lispro 100 [iU]/mL INJECTION, SUSPENSION | Eli | 5 SYRINGE in 1 CARTON (0002-8797-59) / 3... | 100 [iU]/mL | 20 | $10.170 | ● Active | PDAC |
| 00002-8222-59 | Insulin Lispro KwikPen 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 SYRINGE in 1 CARTON (0002-8222-59) / 3... | 100 [iU]/mL | 20 | $10.194 | ● Active | PDAC |
| 00002-8233-05 | Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen 100 [iU]/mL INJECTION, SUSPENSION | Eli | 5 SYRINGE in 1 CARTON (0002-8233-05) / 3... | 100 [iU]/mL | 20 | $10.201 | ● Active | PDAC |
| 00002-7752-05 | Insulin Lispro Junior KwikPen 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 SYRINGE in 1 CARTON (0002-7752-05) / 3... | 100 [iU]/mL | 20 | $10.206 | ● Active | PDAC |
| 00002-7712-27 | Humalog KwikPen Insulin lispro 200 [iU]/mL INJECTION, SOLUTION | Eli | 2 SYRINGE in 1 CARTON (0002-7712-27) / 3... | 200 [iU]/mL | 40 | $20.313 | ● Active | PDAC |
| 00002-8214-05 | BASAGLAR Tempo Pen Insulin glargine 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 SYRINGE in 1 CARTON (0002-8214-05) / 3... | 100 [iU]/mL | 20 | $20.955 | Obsolete | PDAC |
| 00002-8824-27 | Humulin R U-500 KwikPen Insulin human 500 [iU]/mL INJECTION, SOLUTION | Eli | 2 SYRINGE in 1 CARTON (0002-8824-27) / 3... | 500 [iU]/mL | 100 | $91.638 | ● Active | PDAC |
| 00169-3170-97 | Awiqli Insulin icodec-abae 700 U/mL INJECTION, SOLUTION | Novo | 1 SYRINGE in 1 CARTON (0169-3170-97) / 1... | 700 U/mL | 140 | — | ● Active | PDAC |
| 00169-3121-13 | Awiqli Insulin icodec-abae 700 U/mL INJECTION, SOLUTION | Novo | 1 SYRINGE in 1 CARTON (0169-3121-13) / 3... | 700 U/mL | 140 | — | ● Active | PDAC |
| 00169-3105-11 | Awiqli Insulin icodec-abae 700 U/mL INJECTION, SOLUTION | Novo | 1 SYRINGE in 1 CARTON (0169-3105-11) / 1.... | 700 U/mL | 140 | — | ● Active | PDAC |
| 00169-2100-11 | NOVOLOG insulin aspart 100 [iU]/mL INJECTION, SOLUTION | Novo | 1 VIAL, GLASS in 1 CARTON (0169-2100-11)... | 100 [iU]/mL | 20 | — | ● Active | PDAC |
| 00169-2101-25 | NOVOLOG insulin aspart 100 [iU]/mL INJECTION, SOLUTION | Novo | 5 SYRINGE, PLASTIC in 1 CARTON (0169-2101-... | 100 [iU]/mL | 20 | — | ● Active | PDAC |
| 00169-2200-11 | NovoLog Mix 70/30 insulin aspart 100 [iU]/mL INJECTION, SUSPENSION | Novo | 1 VIAL, GLASS in 1 CARTON (0169-2200-11)... | 100 [iU]/mL | 20 | — | ● Active | PDAC |
| 00169-2201-25 | NovoLog Mix 70/30 insulin aspart 100 [iU]/mL INJECTION, SUSPENSION | Novo | 5 SYRINGE, PLASTIC in 1 CARTON (0169-2201-... | 100 [iU]/mL | 20 | — | ● Active | PDAC |
| 00002-8799-61 | HUMALOG KWIKPEN 100 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
| 00002-8797-61 | Humalog Mix75/25 KwikPen Insulin lispro 100 [iU]/mL INJECTION, SUSPENSION | Eli | 1 SYRINGE in 1 CARTON (0002-8797-61) / 3... | 100 [iU]/mL | 20 | — | Obsolete | PDAC |
| 00002-7714-61 | Humalog Junior KwikPen Insulin lispro 100 [iU]/mL INJECTION, SOLUTION | Eli | 1 SYRINGE in 1 CARTON (0002-7714-61) / 3... | 100 [iU]/mL | 20 | — | Obsolete | PDAC |
| 00002-7715-63 | BASAGLAR KwikPen Insulin glargine 100 [iU]/mL INJECTION, SOLUTION | Eli | 1 SYRINGE in 1 CARTON (0002-7715-63) / 3... | 100 [iU]/mL | 20 | — | Obsolete | PDAC |
| 00002-7712-61 | Humalog KwikPen Insulin lispro 200 [iU]/mL INJECTION, SOLUTION | Eli | 1 SYRINGE in 1 CARTON (0002-7712-61) / 3... | 200 [iU]/mL | 40 | — | Obsolete | PDAC |
| 00002-7712-01 | HUMALOG KWIKPEN 200 U/1 ML | Unknown | — | — | 40 | — | — | PDAC |
| 00002-8798-99 | HUMALOG MIX 50/50 KWIKPEN 50 U/1 ML-50 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
| 54868-5327-00 | NOVOLOG MIX 70/30 (PREFILLED SYRINGE) 70 U/ML-30 U/ML | Unknown | — | — | 20 | — | — | PDAC |
| 00002-7516-99 | Humalog Insulin lispro 100 [iU]/mL INJECTION, SOLUTION | Eli | 5 CARTRIDGE in 1 CARTON (0002-7516-99) /... | 100 [iU]/mL | 20 | — | Obsolete | PDAC |
| 00955-1728-05 | INSULIN GLARGINE SOLOSTAR 100 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
| 00955-1729-01 | INSULIN GLARGINE 100 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
| 49502-0195-80 | SEMGLEE 100 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
| 49502-0196-75 | SEMGLEE PEN 100 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
| 00002-7511-99 | HUMALOG MIX 75/25 (VIAL) 75 U/1 ML-25 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
| 00002-7512-01 | HUMALOG MIX 50/50 50 U/ML-50 U/ML | Unknown | — | — | 2 | — | — | PDAC |
| 00002-7512-99 | HUMALOG MIX 50/50 50 U/1 ML-50 U/1 ML | Unknown | — | — | 20 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$0.00
Medicare paid
$0.00
Submitted services
59,154
Denial rate
100.0%
Submitted charges
$104.4K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J1815
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
53 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J1815 billing FAQ
What is HCPCS code J1815?
J1815 is a HCPCS Level II J-code used to bill Injection, insulin, per 5 units under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under J1815?
53 NDCs currently map to J1815 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1815 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.